-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Teradyne, Lowers Price Target to $430

Benzinga·10/29/2026 18:46:45
Listen to the news
UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and lowers the price target from $485 to $430.